TGFB1 and neoplasm: Inquiringly, MSC-EXOs but not EXOs from tumor cells contain TGF-β, C1q, and semaphorins, increasing the myeloid tolerogenic activity with PD-L1 overexpression in immature myelomonocytic precursors and committed CD206+ macrophages [143].